BOOTHBAY FUND MANAGEMENT, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1549230
NEW YORK, NY
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,991,131
+$92,311 QoQ
Shares Held
11,814
-11.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#315
of 772 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Dec 31, 2025CallValue
$1,943,071
CallShares
13,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $84,777,886 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
622,716 | $49,649,146 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
529,640 | $7,748,633 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
74,368 | $6,156,183 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
90,928 | $3,080,640 | |
| 5 | VTRS |
Viatris Inc
|
188,731 | $2,997,048 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
57,516 | $2,082,079 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
11,814 | $1,991,131 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
56,774 | $1,968,354 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,991,131 | 11,814 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $1,943,071 | 13,700 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $1,898,820 | 13,388 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $2,128,183 | 16,932 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $309,680 | 2,800 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $269,269 | 2,337 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,558,424 | 11,320 | Shares | Other | 2024-08-14 | |
| 2024-06-30 | $4,171,401 | 30,300 | Call | Other | 2024-08-14 | |
| 2023-03-31 | $3,707,081 | 36,624 | Shares | Other | 2023-05-15 | |
| 2023-03-31 | $7,227,108 | 71,400 | Put | Other | 2023-05-15 | |
| 2022-06-30 | $416,532 | 4,273 | Shares | Other | 2022-08-15 | |
| 2022-06-30 | $6,014,516 | 61,700 | Call | Other | 2022-08-15 | |
| 2022-03-31 | $7,528,125 | 80,300 | Call | Other | 2022-05-16 | |
| 2022-03-31 | $2,887,500 | 30,800 | Put | Other | 2022-05-16 | |
| 2021-12-31 | $1,471,056 | 17,272 | Shares | Other | 2022-02-14 | |
| 2021-12-31 | $1,439,373 | 16,900 | Put | Other | 2022-02-14 | |
| 2021-12-31 | $1,422,339 | 16,700 | Call | Other | 2022-02-14 | |
| 2021-09-30 | $291,470 | 3,039 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $334,002 | 3,432 | Shares | Other | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||